Acute Pulmonary Embolism and Immunity in Animal Models

Area of Science:

• Cardiovascular Medicine
• Immunology
• Thrombosis Research

Background:

• Venous thromboembolism (VTE), comprising acute pulmonary embolism (APE) and deep vein thrombosis (DVT), is a life-threatening condition.
• Traditional understanding focused on Virchow's triad: endothelial dysfunction, altered blood flow, and hypercoagulability.
• Emerging evidence highlights a central role for immunity, interacting with prothrombotic factors, oxidative stress, and vascular mechanisms.

Purpose of the Study:

• To review and summarize current knowledge on the involvement of immunity in the acute phase of pulmonary embolism.
• To highlight the interplay between immune responses and thrombo-inflammatory processes in APE.
• To identify gaps in understanding, particularly regarding differences between venous and pulmonary thrombi and inflammation in the pulmonary artery.

Main Methods:

• Review of experimental models investigating immunity in acute pulmonary embolism.
• Analysis of the interaction between endothelial injury, immune cell activation, and thrombus formation.
• Examination of factors like hypoxia, cytokine storm, and leukocyte extravasation in thrombo-inflammation.

Main Results:

• Immune system activation is a key event in APE, triggered by endothelial injury.
• Inflammation amplifies thrombosis through leukocyte, platelet, and endothelial cell activation.
• Right ventricular strain, hypoxia, and cytokine release contribute to myocardial injury and thrombo-inflammatory processes.

Conclusions:

• Immunity plays a critical role in the pathophysiology of acute pulmonary embolism.
• Further research is needed to elucidate chemokine and cellular differences in thrombi and the inflammatory state of the pulmonary artery during APE.
• Understanding these immune mechanisms is crucial for developing targeted therapies for APE.